The negative-feedback regulation of the IL-13 signal by the IL-13 receptor α2 chain in bronchial epithelial cells

Cytokine

Volumn 24, Issue 6, 2003, Pages 293-303

  Yasunaga, Shinichiro ^a   Yuyama, Noriko ^b   Arima, Kazuhiko ^a   Tanaka, Hiroyuki ^c   Toda, Shuji ^a   Maeda, Miyako ^b   Matsui, Keiko ^b   Goda, Chiho ^a   Yang, Qing ^a,d   Sugita, Yuji ^b   Nagai, Hiroichi ^c   Izuhara, Kenji ^a  

^a SAGA UNIVERSITY   (Japan)

^b Genox Research Inc   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^d JIANGXI MEDICAL COLLEGE   (China)

Author keywords

Allergy; Cytokine; Cytokine receptor; Lung; Signal transduction

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; MONOMER; RECEPTOR SUBUNIT; STAT6 PROTEIN;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG PARENCHYMA; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 10744229896     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.08.006     Document Type: Article

References (47)

1. Holgate S.T. The epidemic of allergy and asthma. Nature. 402:1999;B2-B4.
2. Akimoto T., Numata F., Tamura M., Takata Y., Higashida N., Takashi T., et al. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J Exp Med. 187:1998;1537-1542.
3. Cohn L., Homer R.J., MacLeod H., Mohrs M., Brombacher F., Bottomly K. Th2-induced airway mucus production is dependent on IL-4Rα, but not on eosinophils. J Immunol. 162:1999;6178-6183.
4. Webb D.C., McKenzie A.N., Koskinen A.M., Yang M., Mattes J., Foster P.S. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol. 165:2000;108-113.
5. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., et al. Interleukin-13: central mediator of allergic asthma. Science. 282:1998;2258-2261.
6. Grünig G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M., et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 282:1998;2261-2263.
7. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 103:1999;779-788.
8. Kuperman D.A., Huang X., Koth L.L., Chang G.H., Dolganov G.M., Zhu Z., et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med. 8:2002;885-889.
9. Kotsimbos T.C., Ernst P., Hamid Q.A. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc Assoc Am Physicians. 108:1996;368-373.
10. Bodey K.J., Semper A.E., Redington A.E., Madden J., Teran L.M., Holgate S.T., et al. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. Allergy. 54:1999;1083-1093.
11. Heinzmann A., Mao X.Q., Akaiwa M., Kreomer R.T., Gao P.S., Ohshima K., et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet. 9:2000;549-559.
12. Arima K., Umeshita-Suyama R., Sakata Y., Akaiwa M., Mao X.Q., Enomoto T., et al. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol. 109:2002;980-987.
13. Izuhara K., Umeshita-Suyama R., Akaiwa M., Shirakawa T., Deichmann K.A., Arima K., et al. Recent advances in understanding how interleukin-13 signals are involved in the pathogenesis of bronchial asthma. Arch Immunol Ther Exp. 48:2000;505-512.
14. Izuhara K., Arima K., Yasunaga S. IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies. Curr Drug Targets Inflamm Allergy. 1:2002;263-269.
15. Orchansky P.L., Kwan R., Lee F., Schrader J.W. Characterization of the cytoplasmic domain of interleukin-13 receptor-α J Biol Chem. 274:1999;20818-20825.
16. Umeshita-Suyama R., Sugimoto R., Akaiwa M., Arima K., Yu B., Wada M., et al. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor α chain 1: redundancy of requirement of tyrosine residue for STAT3 activation. Int Immunol. 12:2000;1499-1509.
17. Ogata H., Ford D., Kouttab N., King T.C., Vita N., Minty A., et al. Regulation of interleukin-13 receptor constituents on mature human B lymphocytes. J Biol Chem. 273:1998;9864-9871.
18. Akaiwa M., Yu B., Umeshita-Suyama R., Terada N., Suto H., Koga T., et al. Localization of human interleukin 13 receptor in non-haematopoietic cells. Cytokine. 13:2001;75-84.
19. Ihle J.N., Witthuhn B.A., Quelle F.W., Yamamoto K., Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol. 13:1995;369-398.
20. Kawakami K., Taguchi J., Murata T., Puri R.K. The interleukin-13 receptor α2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood. 97:2001;2673-2679.
21. Bernard J., Treton D., Vermot-Desroches C., Boden C., Horellou P., Angevin E., et al. Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Rα2 as a decoy receptor for IL13. Lab Invest. 81:2001;1223-1231.
22. Yuyama N., Davies D.E., Akaiwa M., Matsui K., Hamasaki Y., Suminami Y., et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine. 19:2002;287-296.
23. Tanaka H., Kawada N., Yamada T., Kawada K., Takatsu K., Nagai H. Allergen-induced airway inflammation and bronchial responsiveness in interleukin-5 receptor α chain-deficient mice. Clin Exp Allergy. 30:2000;874-881.
24. Daines M.O., Hershey G.K. A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor α-2 and their rapid mobilization by interferon-γ J Biol Chem. 277:2002;10387-10393.
25. Jakubzick C., Kunkel S.L., Joshi B.H., Puri R.K., Hogaboam C.M. Interleukin-13 fusion cytotoxin arrests Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. Am J Pathol. 161:2002;1283-1297.
26. Chiaramonte M.G., Mentink-Kane M., Jacobson B.A., Cheever A.W., Whitters M.J., Goad M.E., et al. Regulation and function of the interleukin 13 receptor α 2 during a T helper cell type 2-dominant immune response. J Exp Med. 197:2003;687-701.
27. Aman M.J., Tayebi N., Obiri N.I., Puri R.K., Modi W.S., Leonard W.J. cDNA cloning and characterization of the human interleukin 13 receptor α chain. J Biol Chem. 271:1996;29265-29270.
28. Caput D., Laurent P., Kaghad M., Lelias J.-M., Lefort S., Vita N., et al. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J Biol Chem. 271:1996;16921-16926.
29. Wood N., Whitters M.J., Jacobson B.A., Witek J., Sypek J.P., Kasaian M., et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor α 2. J Exp Med. 197:2003;703-709.
30. Yasukawa H., Sasaki A., Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol. 18:2000;143-164.
31. Mantovani A., Locati M., Vecchi A., Sozzani S., Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 22:2001;328-336.
32. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science. 261:1993;472-475.
33. Zheng T., Zhu Z., Wang Z., Homer R.J., Ma B., Riese R.J., et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest. 106:2000;1081-1093.
34. Blum H., Wolf M., Enssle K., Röllinghoff M., Gessner A. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor. J Immunol. 157:1996;1846-1853.
35. Zhang J.G., Hilton D.J., Willson T.A., McFarlane C., Roberts B.A., Moritz R.L., et al. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned IL-13 receptor and IL-4 receptor α-chains. J Biol Chem. 272:1997;9474-9480.
36. Schindler C., Darnell J.E. Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 64:1995;621-651.
37. Lee J.H., Kaminski N., Dolganov G., Grunig G., Koth L., Solomon C., et al. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am J Respir Cell Mol Biol. 25:2001;474-485.
38. Gao P.-S., Mao X.-Q., Arinobu Y., Izuhara K., Roberts M.H., Deichmann K.A., et al. Stat6 and atopic asthma. J Med Genet. 37:2000;380-382.
39. Mitsuyasu H., Izuhara K., Mao X.-Q., Gao P.-S., Arinobu Y., Enomoto T., et al. Ile50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma. Nat Genet. 19:1998;119-120.
40. Mitsuyasu H., Yanagihara Y., Mao X.-Q., Gao P.-S., Arinobu Y., Ihara K., et al. Dominant effect of Ile50Val variant of the human interleukin-4 receptor α chain in IgE synthesis. J Immunol. 162:1999;1227-1231.
41. Lordan J.L., Bucchieri F., Richter A., Konstantinidis A., Holloway J.W., Thornber M., et al. Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol. 169:2002;407-414.
42. Sugiyama N., Tabuchi Y., Numata F., Uchida Y., Horiuchi T., Ishibashi K., et al. Establishment and characterization of tracheal epithelial cell lines, TM01 and TM02-3, from transgenic mice bearing temperature-sensitive simian virus 40 large T-antigen gene. Cell Struct Funct. 23:1998;119-127.
43. Mikita T., Campbell D., Wu P., Williamson K., Schindler U. Requirements for interleukin-4-induced gene expression and functional characterization of Stat6. Mol Cell Biol. 16:1996;5811-5820.
44. Masuda A., Matsuguchi T., Yamaki K., Hayakawa T., Kubo M., LaRochelle W.J., et al. Interleukin-15 induces rapid tyrosine phosphorylation of STAT6 and the expression of interleukin-4 in mouse mast cells. J Biol Chem. 275:2000;29331-29337.
45. Toda S., Matsumura S., Fujitani N., Nishimura T., Yonemitsu N., Sugihara H. Transforming growth factor-β1 induces a mesenchyme-like cell shape without epithelial polarization in thyrocytes and inhibits thyroid folliculogenesis in collagen gel culture. Endocrinology. 138:1997;5561-5575.
46. Izuhara K., Heike T., Otsuka T., Yamaoka K., Mayumi M., Imamura T., et al. Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J Biol Chem. 271:1996;619-622.
47. Izuhara K., Miyajima A., Harada N. The chimeric receptor between interleukin-2 receptor β chain and interleukin-4 receptor transduces interleukin-2 signal. Biochem Biophys Res Commun. 190:1993;992-1000.